HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Julie Meade Selected Research

Abdominal Pain (Pain, Abdominal)

11/2021Clinical Benefit of Ripretinib Dose Escalation After Disease Progression in Advanced Gastrointestinal Stromal Tumor: An Analysis of the INVICTUS Study.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Julie Meade Research Topics

Disease

5Gastrointestinal Stromal Tumors (Gastrointestinal Stromal Tumor)
12/2022 - 11/2021
3Disease Progression
11/2021 - 01/2020
2Neoplasms (Cancer)
12/2021 - 11/2021
1Alopecia (Baldness)
12/2022
1Abdominal Pain (Pain, Abdominal)
11/2021
1Anemia
11/2021
1Acute Kidney Injury (Acute Renal Failure)
01/2020
1Dehydration (Water Stress)
01/2020
1Fatigue
01/2020
1Hypertension (High Blood Pressure)
01/2020
1Septic Shock (Toxic Shock Syndrome)
01/2020

Drug/Important Bio-Agent (IBA)

7ripretinibIBA
12/2022 - 01/2020
2Tyrosine Kinase InhibitorsIBA
12/2022 - 12/2021
2Imatinib Mesylate (Gleevec)FDA Link
12/2022 - 10/2022
1Sunitinib (Sutent)FDA Link
12/2022
1Phosphotransferases (Kinase)IBA
10/2022
1Circulating Tumor DNAIBA
12/2021
1Lipase (Acid Lipase)FDA Link
01/2020

Therapy/Procedure

1Aftercare (After-Treatment)
12/2022
1Duration of Therapy
11/2021
1Therapeutics
11/2021